| Rank | Title | Journal | Year | PubWeight™‹?› |
|---|---|---|---|---|
| 1 | Asymmetric dimethylarginine (ADMA): an endogenous inhibitor of nitric oxide synthase and a novel cardiovascular risk molecule. | Med Sci Monit | 2009 | 1.01 |
| 2 | The Genesis II in primary total knee replacement: a systematic literature review of clinical outcomes. | Knee | 2011 | 0.87 |
| 3 | L-arginine, asymmetric dimethylarginine, and symmetric dimethylarginine in plasma and synovial fluid of patients with knee osteoarthritis. | Med Sci Monit | 2013 | 0.83 |
| 4 | Does primary or secondary chondrocalcinosis influence long-term survivorship of unicompartmental arthroplasty? | Clin Orthop Relat Res | 2011 | 0.81 |
| 5 | Custom-made articulating spacer in two-stage revision total knee arthroplasty. An early follow-up of 14 cases of at least 1 year after surgery. | HSS J | 2007 | 0.78 |